Amgen (AMGN) Operating Margin (2009 - 2026)

Amgen has reported Operating Margin for 18 years, with the latest figure at 34.95% in Q2 2026.

• On a quarterly basis, Operating Margin rose 602.0% year-over-year to 34.95% in Q2 2026; TTM through Jun 2026 was 29.99%, a 653.0% increase from a year earlier, with the FY2025 full-year figure at 24.71%, up 299.0% from the prior year.
• Operating Margin was 34.95% for Q2 2026 at Amgen, up from 30.94% in the prior quarter.
• The five-year high for Operating Margin was 485.84% in Q4 2022, with the low at 13.31% in Q1 2024.
• Average Operating Margin over 5 years is 53.47%, with a median of 29.11% recorded in 2023.
• The sharpest annual moves came in 2022 and 2023: Operating Margin soared 45218 bps in 2022, then tumbled 47033 bps in 2023.
• Over 5 years, Operating Margin stood at 485.84% in 2022, then tumbled by 97 bps to 15.51% in 2023, then soared by 64 bps to 25.43% in 2024, then increased by 8 bps to 27.57% in 2025, then grew by 27 bps to 34.95% in 2026.
• The last three Operating Margin figures came in at 34.95% (Q2 2026), 30.94% (Q1 2026), and 27.57% (Q4 2025), per Business Quant data.